The Drugs Technical Advisory Board (DTAB), the highest body under the Union Health Ministry on technical matters concerning the pharma industry in the country, will re-examine the controversial drug letrozole which is indicated for sub-fertility in young menstruating women in the country. The DTAB is meeting on November 9.
The details can be read here.
No comments:
Post a Comment